HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of flunixin meglumine in dogs following experimentally induced endotoxemia.

Abstract
Twelve dogs were randomly divided into three groups. Group 1 dogs were given Escherichia coli endotoxin and then treated with flunixin meglumine. Group 2 dogs were given endotoxin as group 1, but untreated. Group 3 dogs were given flunixin meglumine alone. The dogs were monitored clinically and urine and serum samples were collected at regular intervals for 72 hours. All surviving dogs were humanely killed after 72 hours and examined for gross and histologic lesions. Group 1 dogs all survived 72 hours, but showed prerenal azotemia, hepatocellular damage, hemorrhagic enteritis, and numerous gastric ulcerations. Three of the four dogs in group 2 died before 72 hours. Group 2 dogs showed many of the same chemical and hemodynamic changes as group 1. They had severe hemorrhage into the intestinal lumen; however, there were no gastric ulcerations. Group 3 dogs all survived and showed little physical or hematologic change. The study suggested the following: 1) flunixin meglumine was an effective drug in ameliorating the fatal effects of canine endotoxemia, 2) the effects of endotoxin in combination with flunixin meglumine, at 1.1 mg/kg body weight, caused gastric ulcerations, and 3) in normal dogs flunixin meglumine at 1.1 mg/kg body weight did not cause severe side effects or gross lesions.
AuthorsB L Stegelmeier, G D Bottoms, D B Denicola, W M Reed
JournalThe Cornell veterinarian (Cornell Vet) Vol. 78 Issue 3 Pg. 221-30 (Jul 1988) ISSN: 0010-8901 [Print] United States
PMID3042277 (Publication Type: Journal Article)
Chemical References
  • Endotoxins
  • Nicotinic Acids
  • flunixin meglumine
  • Clonixin
Topics
  • Animals
  • Clonixin (analogs & derivatives, therapeutic use)
  • Dog Diseases (drug therapy, pathology)
  • Dogs
  • Endotoxins (administration & dosage, toxicity)
  • Escherichia coli
  • Escherichia coli Infections (drug therapy, pathology, veterinary)
  • Female
  • Male
  • Nicotinic Acids (therapeutic use)
  • Random Allocation
  • Shock, Septic (drug therapy, pathology, veterinary)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: